Author:
Mandalà M,Grosso F,Vitalini C,Corradino I,Sanfilippo R,Colombini S,Clerici M,Labianca R,De Pascale A,Marsoni S
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Cao Y, Tan A, Gao F, Liu L, Liao C, Mo Z (2009) A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer. Int J Colorectal Dis 24: 677–685
2. Cassier PA, Moreno Garcia V, Gomez-Roca C, Olmos D, Morales R, Del Conte G, Gallerani E, Brunetto A, Schoffski P, Marsoni S, Schellens JHM, Penel N, Voest EE, Evans TRJ, Plummer R, Wilson RH, Soria J, Tabernero J, Verweij J, Kaye SB European Drug Development Network (2011) Dose-response relationship in phase I clinical trials: a European Dose Drug Development Network (EDDN) collaboration study Proceedings of the American Society of Clinical Oncology. J Clin Oncol 29 (Suppl): ): Abstr 3084
3. Falanga A, Levine MN, Consonni R, Gritti G, Delaini F, Oldani E, Julian JA, Barbui T (1998) The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial. Thromb Haemost 79: 23–27
4. Falanga A, Zacharski L (2005) Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol 16: 696–701
5. Kabbinavar FF, Hurwitz HI, Yi J, Sarkar S, Rosen O (2009) Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials. J Clin Oncol 27: 199–205
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献